Comparison of the effect of Epinephrine containing Lidocaine and Mepivacaine on glycemic level

Comparison of the impact of two local anesthesia (Epinephrine containing Lidocaine & Mepivacaine) On glycemic level

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181114041651N1

Enrollment

100

Registered

2022-10-31

Start date

2022-10-19

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes. Diabetes mellitus due to underlying condition

Interventions

Intervention 1: Control group: The patients who recieve Mepivacaine (Epinephrine free) as anesthetic agent. Intervention 2: Intervention group: Patients who recieve Lidocaine (Containing Epinephrine)

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Patients within the age of 18 to 50 years Patients who have had breakfast at least one hour ago

Exclusion criteria

Exclusion criteria: Patients who have addiction Diabetic patients (controlled or uncontrolled) Patients who are allergic to local anesthetic agents or NSAIDs Patients who show allergic reactions after the injection Highly stressed patients Patients who show resistance to the injected anesthetic agent and need more than three carpules Lidocaine contraindication cases

Design outcomes

Primary

Measure	Time frame
Glucose level. Timepoint: Before intervention and 20 minutes after the local anesthesia injection. Method of measurement: Blood glucose meter.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEhsan Aliabadi

Shiraz University of Medical Sciences

aliabadie@sums.ac.ir+98 71 3626 3193

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026